Streetbeat News

Stock Prices

CTVA

Analysts have mixed views on Corteva (NYSE:CTVA), with recent updates showing a mix of bullish and bearish ratings. The average 12-month price target is $61.3, reflecting a 4.89% increase from the previous target. Corteva, an agriculture company, has seen a revenue decline of -3.08% as of December 31, 2023, but maintains a strong market position with a notable net margin and ROA.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 1:01 pm

EFX

Equifax (NYSE:EFX) has been analyzed by 5 analysts in the last three months, showing a range of perspectives from bullish to bearish. The average 12-month price target for EFX is now $292.6, up 16.57% from the previous target of $251. Equifax's financial performance is strong, with a revenue growth rate of 10.74% as of December 31, 2023, and a net margin of 9.98%. However, its ROE of 3.0% is below industry averages, and its debt-to-equity ratio of 1.26 suggests high debt levels.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 1:00 pm

AVDX

AvidXchange Holdings (NASDAQ:AVDX) was analyzed by 6 analysts, showing a shift towards a more cautious stance with 4 indifferent ratings recently. The 12-month price targets suggest optimism with an average target of $14.08, up from $12.80. The company's financials indicate a strong revenue growth of 20.76% but challenges in profitability and efficiency, with a net margin of -4.3% and ROE of -0.69%.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 1:00 pm

APTV

DAL

UBER

Delta Air Lines, Uber Technologies, and Aptiv were featured on CNBC's 'Final Trades'. Delta is expected to report strong quarterly earnings with an increase in EPS and revenue. Uber's price target was raised by Wells Fargo, and Aptiv is anticipated to report higher earnings and revenue for its first quarter. Delta and Aptiv's stock prices increased, while Uber's decreased in the last trading session.

Portfolio Pulse from Avi Kapoor

April 09, 2024 | 12:59 pm

GXO

JP Morgan analyst Brian Ossenbeck has maintained an Overweight rating on GXO Logistics (NYSE:GXO) but has lowered the price target from $67 to $65.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:56 pm

ACRV

LASE

VVOS

Laser Photonics (LASE) shares surged 167% after securing an order from L3Harris Technologies for its LaserTower COMPACT system. Acrivon Therapeutics (ACRV) shares jumped 87% following a $130 million private placement financing. Vivos Therapeutics (VVOS) shares increased 53% as its CARE Oral Medical Devices received full Medicare reimbursement approval and announced an offer for sale of up to 1.7M shares by a selling stockholder.

Portfolio Pulse from ryanfaloona@benzinga.com

April 09, 2024 | 12:56 pm

ALLR

Trading for ALLR was halted and then resumed at 8:55 AM ET, following an update on halt status. This event indicates a significant occurrence that required temporary suspension of trading for ALLR.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:55 pm

PSMT

PriceSmart, Inc. (NASDAQ:PSMT) is expected to release its Q2 earnings on April 9, 2024, with analysts projecting an earnings increase to $1.25 per share from $1.02 the previous year, and revenue of $1.28 billion. The company recently raised its annual dividend to $1.16 per share, yielding 1.39%. To earn a $500 monthly dividend income, an investor would need to own approximately 5,172 shares, valued around $432,017. The article also explains how dividend yield changes with stock price and dividend payment adjustments. PSMT's stock rose 0.7% to close at $83.53 recently.

Portfolio Pulse from Avi Kapoor

April 09, 2024 | 12:53 pm

GATO

Gatos Silver shares are experiencing an uptick due to the overall strength in precious metals stocks, which is being driven by rising gold and silver prices.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:49 pm

NSC

Norfolk Southern's shares dropped following the announcement of preliminary Q1 results, which include a $600 million agreement to settle a class action lawsuit related to the East Palestine derailment.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:45 pm